| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Pregnancy Complications | D011248 | 19 associated lipids |
| Down Syndrome | D004314 | 18 associated lipids |
| Alcoholic Intoxication | D000435 | 15 associated lipids |
| Angina, Unstable | D000789 | 14 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Respiratory Syncytial Virus Infections | D018357 | 10 associated lipids |
| Aortic Aneurysm | D001014 | 8 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Falardeau P et al. | Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. | 1985 | Prostaglandins | pmid:3890022 |
| McAdam BF et al. | Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9874808 |
| Praticò D et al. | Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11248083 |
| Saareks V et al. | Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. | 2002 | Pharmacol. Toxicol. | pmid:12403056 |
| Ylikorkala O et al. | Urinary prostacyclin and thromboxane metabolites in drinking pregnant women and in their infants: relations to the fetal alcohol effects. | 1988 | Obstet Gynecol | pmid:3275910 |
| Rauramo I et al. | Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. | 1995 | Obstet Gynecol | pmid:7770249 |
| Yuhki K et al. | [Prostaglandin I2 and its metabolites]. | 2010 | Nippon Rinsho | pmid:20960743 |
| Goldberg MR et al. | Prostacyclin biosynthesis and platelet function in autonomic dysfunction. | 1985 | Neurology | pmid:3838109 |
| Fitzgerald DJ et al. | Platelet activation in unstable coronary disease. | 1986 | N. Engl. J. Med. | pmid:3531859 |
| Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
| Christman BW et al. | An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. | 1992 | N. Engl. J. Med. | pmid:1603138 |
| FitzGerald GA et al. | Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. | 1984 | N. Engl. J. Med. | pmid:6231483 |
| Knapp HR et al. | In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. | 1986 | N. Engl. J. Med. | pmid:3007982 |
| Falardeau P and Brash AR | Quantitation of two dinor metabolites of prostacyclin by GC-MS. | 1982 | Meth. Enzymol. | pmid:6752645 |
| Edlund A et al. | Myocardial ischaemia triggers formation of thromboxane. | 1987 | Lancet | pmid:2887865 |
| Gréen K et al. | Deficient prostacyclin formation after acute myocardial infarction. | 1987 | Lancet | pmid:2883378 |
| Watson ML et al. | Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome. | 1983 | Lancet | pmid:6135873 |
| Liggins GC et al. | Prostacyclin and maternal lupus anticoagulant. | 1984 | Lancet | pmid:6140483 |
| Tulppala M et al. | Thromboxane dominance and prostacyclin deficiency in habitual abortion. | 1991 | Lancet | pmid:1672969 |
| Stichtenoth DO et al. | Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers. | 2005 | Kidney Int. | pmid:16221219 |
| Mills JL et al. | Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. | 1999 | JAMA | pmid:10432033 |
| Hashimoto K et al. | Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. | 2004 | J. Virol. | pmid:15367596 |
| Lin JS et al. | The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. | 1992 | J. Urol. | pmid:1635125 |
| Neiman J et al. | Effects of a small dose of ethanol and calcium carbimide-induced acetaldehyde intoxication on human platelet aggregation, associated thromboxane formation and urinary excretion of 2,3-dinor-6-keto prostaglandin F1 alpha. | 1987 | J. Toxicol. Clin. Toxicol. | pmid:3612897 |
| Brown NJ et al. | Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin. | 1996 | J. Pharmacol. Exp. Ther. | pmid:8930174 |
| Catella-Lawson F et al. | Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. | 1999 | J. Pharmacol. Exp. Ther. | pmid:10215647 |
| Capone ML et al. | Human pharmacology of naproxen sodium. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17473175 |
| Kuehl PG et al. | Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants. | 1986 | J. Pediatr. | pmid:3519915 |
| Mastrogiannis DS et al. | Cocaine decreases urinary prostacyclin release in pregnancy: correlation with uterine and umbilical Doppler velocimetry. | 2003 | J. Matern. Fetal. Neonatal. Med. | pmid:15061316 |
| Morrow JD et al. | Increased formation of thromboxane in vivo in humans with mastocytosis. | 1999 | J. Invest. Dermatol. | pmid:10417625 |
| Rasmanis G et al. | Prostacyclin production in myocardial infarction in the acute phase and during follow-up. | 1991 | J. Intern. Med. | pmid:1997639 |
| Barden AE et al. | Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? | 1999 | J. Hypertens. | pmid:10489109 |
| Kimblad PO et al. | Prostanoid release after lung transplantation. | 1996 | J. Heart Lung Transplant. | pmid:8913917 |
| Neiman J et al. | Urinary excretion of 2, 3-dinor-6-keto prostaglandin F1 alpha and platelet thromboxane formation during ethanol withdrawal in alcoholics. | 1987 | J. Clin. Pathol. | pmid:3584500 |
| Fitzgerald DJ et al. | Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis. | 1988 | J. Clin. Invest. | pmid:3183064 |
| Dowd NP et al. | Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. | 2001 | J. Clin. Invest. | pmid:11518732 |
| Song WL et al. | Niacin and biosynthesis of PGDâ‚‚by platelet COX-1 in mice and humans. | 2012 | J. Clin. Invest. | pmid:22406532 |
| Ylikorkala O et al. | Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. | 1987 | J. Clin. Endocrinol. Metab. | pmid:2960690 |
| Ylikorkala O et al. | Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. | 1986 | J. Clin. Endocrinol. Metab. | pmid:3536979 |
| Mizugaki M et al. | Microdetermination of 2,3-dinor-6-ketoprostaglandin F1 alpha in human urine using gas chromatography-high-resolution selected-ion monitoring. | 1994 | J. Chromatogr. B, Biomed. Appl. | pmid:7952110 |
| Daniel VC et al. | Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. | 1994 | J. Chromatogr. B, Biomed. Appl. | pmid:8205238 |
| Casas J et al. | Determination of 2,3-dinor-6-ketoprostaglandin F1 alpha in urine samples by liquid chromatography and radioimmunoassay. | 1986 | J. Chromatogr. | pmid:3558562 |
| Ferretti A and Flanagan VP | Assay of urinary 2,3-dinor-6-oxo prostaglandin F1 alpha by gas chromatography-tandem mass spectrometry. | 1993 | J. Chromatogr. | pmid:8150859 |
| Chiabrando C et al. | Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. | 1989 | J. Chromatogr. | pmid:2613794 |
| Böger RH et al. | Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin. | 1995 | J. Appl. Physiol. | pmid:7649919 |
| Hamm CW et al. | Biochemical evidence of platelet activation in patients with persistent unstable angina. | 1987 | J. Am. Coll. Cardiol. | pmid:3668113 |
| Benowitz NL et al. | Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. | 1993 | J. Am. Coll. Cardiol. | pmid:7691912 |
| Lindström T et al. | The effect of unreamed and reamed intramedullary nailing on the urinary excretion of prostacyclin and thromboxane A2 metabolites in patients with tibial shaft fractures. | 1998 | J Trauma | pmid:9783614 |
| Ritter JM et al. | Prostacyclin biosynthesis in essential hypertension before and during treatment. | 1996 | J Hum Hypertens | pmid:8642189 |
| Schwartz JI et al. | Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. | 2007 | J Clin Pharmacol | pmid:17925592 |